NumFin

Abiomed, Inc.

Sembol: ABMD

NASDAQ

381.02

USD

Bugünkü piyasa fiyatı

  • 126.8485

    F/K Oranı

  • -5.7181

    PEG Oranı

  • 17.18B

    MRK Kapağı

  • 0.00%

    DIV Verimi

Abiomed, Inc. (ABMD) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Abiomed, Inc. (ABMD). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

Abiomed, Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

balance-sheet.row.cash-and-short-term-investments

3092.52758.6583.7443.1
491.7
362.2
229.9
212.1
132
76.6
76.7
77.2
60.3
58.3
57.2
38.3
75.1
30.8
41.5
27.3
54.4
71.3
92.5
106.4
18.2
26.4
9.4
10.6
0.6
0.5
0.7
4.7
8.1
24.6
10.4
13.3
2.4

balance-sheet.row.short-term-investments

2452.62625.8351250.8
370.7
319.3
190.9
163.8
109.6
55.7
67.3
71.2
54.5
53.5
55.4
36.3
5.5
23
33.9
20.4
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

365.1490.697.284.7
90.8
70
54.1
42.8
31.8
24.4
22.9
20.5
15.4
13.5
15.7
14.1
10.9
8.9
8.6
6
5.4
7.3
10
6.7
6.4
5.4
4.8
2.6
1.8
1.7
0.8
0.6
0.7
0.7
0.8
0.5
0.2

balance-sheet.row.inventory

381.799481.190.1
80.9
50.2
34.9
26.7
16.8
13.9
14.9
11.1
7.5
9.2
14.8
17.4
8.6
4.9
3.9
2.7
2.9
4.2
3.7
3.5
2.9
2.3
1.8
1.7
1.4
2.2
1.5
0.9
1.2
1.1
0.9
0.6
0.4

balance-sheet.row.other-current-assets

145.1933.32618
13.7
11.8
8
6.8
39.6
3.1
2
1.7
1.5
1.7
0.8
1.7
1.8
1.9
1.2
1
0.9
0.8
0.8
0.5
0.3
0.2
0.2
0.1
3.9
2.7
9
13.8
14
0.2
0.1
0
0.4

balance-sheet.row.total-current-assets

3984.64976.5788635.9
677.2
494.3
327
288.4
220.1
118
116.6
110.5
84.7
82.7
88.5
71.5
96.4
46.4
55.2
37
63.6
83.7
107
117.1
27.8
34.3
16.2
15
7.7
7.1
12
20
24
26.6
12.2
14.4
3.4

balance-sheet.row.property-plant-equipment-net

827.51212203.2176.7
145
117.2
87.8
23.2
9.1
6.9
6.5
6.4
6.3
6.8
7.8
7.6
5.8
4.8
2.8
3.2
4
4.7
4.8
4
3.9
3.7
1.9
0.6
0.5
0.6
0.7
0.6
1.1
1.1
0.3
0.3
0.3

balance-sheet.row.goodwill

302.0576.878.632
32.6
35.8
31
33
31.5
38
35.4
36.8
38.9
37.2
31.3
31.6
26.7
19.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

190.6345.647.522.6
15.2
16.7
14.5
15.4
14.7
0
0
0.1
1.6
3
4.4
6.9
7.3
8.2
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

492.68122.412654.5
47.8
52.5
45.5
48.4
46.2
38
35.4
37
40.6
40.1
35.7
38.5
34
27.3
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.long-term-investments

1311.42351.9365.7302.2
21.7
37.5
47.1
1
14
41.8
11.4
0
0
0
3.7
0
0
0
2.1
18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

50.2110.611.443.3
77.5
70.7
34.7
58.5
45.2
0
0
0
0
0
0
0
0
0.3
-2.1
-18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0003.8
85.1
14.2
8.3
4.4
3.7
0.8
0
0
0
0
0.3
0.5
0
-0.3
2.1
18.2
0
1.1
6.3
0.7
1.3
0.6
0.5
0.6
6.5
7.6
9.5
5
4.5
0
0
0
0

balance-sheet.row.total-non-current-assets

2681.81696.9706.4580.6
377.1
292.1
223.5
135.5
118.2
87.4
53.4
43.4
46.9
46.9
47.5
46.5
39.8
32.1
5.8
22.2
4.8
5.8
11
4.6
5.1
4.3
2.4
1.2
7
8.3
10.4
5.8
5.9
1.1
0.3
0.3
0.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.account-payables

137.2835.334.832.8
32.2
23.6
20.6
9.4
10.4
7.7
7.7
6.9
6.3
3.8
5.5
9
5.2
3.1
1.1
1.4
1.1
2
2.1
1.6
0.9
2.1
1.3
0.8
0.2
0.4
0.5
0.4
0.3
0
0
0
0

balance-sheet.row.short-term-debt

66.6706675.1
12.3
4.6
0.8
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

20.021.95.921.6
12.3
4.6
3.2
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
0
15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
-15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

235.3176.73.84.9
45.2
41.6
37.7
25.9
20.4
16.5
13.1
11.5
14.1
13
10.8
9.3
7
5.2
3.6
3.3
4.2
5.6
5.6
6.4
4.8
2.9
2
1.5
1.2
0.7
0.7
0.8
0.6
1.3
1.2
1.2
1.4

balance-sheet.row.total-non-current-liabilities

114.1331.635.719.1
11.5
12.2
28.7
8.6
7.5
6.6
5.9
5.2
4.5
3.5
2.4
5
1.2
0.3
0
0
0
0
0.4
0.7
0.2
0.7
0
0
0
3.7
8.7
8.3
7.8
0
0
0
-0.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

654.2170.1164.7151
117.5
96.9
98.3
55.2
46.8
37.1
32.9
27.6
26.8
21.6
20
24.4
14.1
9
4.9
4.8
6.2
10.2
9.3
8.9
5.9
5.6
3.3
2.3
1.4
4.8
9.9
9.5
8.7
1.3
1.2
1.2
1.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1.820.50.50.5
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

4012.96964.5828602.5
399.5
140.5
-47
-99.1
-137.2
-250.9
-258.3
-273.3
-274.8
-263
-244
-212.4
-171.2
-143.3
-113.9
-111.5
-102.1
-84.4
-53.1
-41.7
-31.2
-24.5
-22
-22.8
-23.2
-22.9
-20.9
-17
-11.9
-5.3
-3.4
-1.1
-0.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-132.56-27.2-11.4-11.2
-14.7
-4.2
-20.6
-14.5
-17.3
-0.7
-3.7
-1.8
0.7
-1
-1.7
5
0.6
-2.1
-0.3
-0.1
-8.6
3.1
3.1
-5.4
-3.9
-2.7
-2.6
-2.3
-2.1
-1.9
-1.6
-1.4
-1.1
-0.8
-0.7
-0.5
-0.3

balance-sheet.row.other-total-stockholders-equity

2130.03565.5512.7473.7
551.7
552.8
519.2
482
445.7
419.6
398.7
400.9
378.4
371.6
361.3
300.7
292.4
214.6
170.1
165.7
172.5
160.4
158.4
159.9
62.1
60.2
39.8
39
38.6
35.4
35
34.7
34.2
32.5
15.4
15.1
3.3

balance-sheet.row.total-stockholders-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-stockholders-equity

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-total-equity

6666.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

3764.04977.7716.7553
392.4
356.8
238.1
164.8
123.6
97.4
78.7
71.2
54.5
53.5
59.1
36.3
5.5
23
36
38.6
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-639.9-132.8-232.7-192.3
-121
-43
-22.7
-48.2
-22.4
-20.9
-9.5
-6
-5.8
-4.8
-1.8
-2
-69.6
-7.8
-7.6
-6.9
-44.6
-45.6
-90.2
-101.7
-9.3
-2.7
-1.6
-2.9
-0.6
-0.5
-0.7
-4.7
-8.1
-24.6
-10.4
-13.3
-2.4

Nakit Akış Tablosu

Abiomed, Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6

cash-flows.row.depreciation-and-amortization

27.5628.124.120.4
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3

cash-flows.row.deferred-income-tax

-13.22.429.433
-7.7
42.6
25.8
22.3
-87.1
0.9
0.8
0.8
1
1
0.7
0.5
0.5
0.3
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

53.7552.74739.8
54.5
40.4
32.9
29.1
16.5
11.2
9.5
7.8
5.4
5.4
8.8
5.4
5.8
0.4
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-23.26-30.2-17.48
-38.8
-18.9
5.3
-15.6
-4.7
-0.5
-2.8
-11.7
0.5
3.6
-3.5
-8
-2.5
2.8
-4.1
-2.1
-0.2
-0.4
-3.5
1.5
-2.1
0.9
-1.4
-0.3
1.1
-1.8
-0.8
0.9
-0.7

cash-flows.row.account-receivables

-8.515.3-12.15.6
-22
-15.3
-11.6
-10.9
-8
-1.3
-2.6
-5.3
-1.9
2.2
-2.5
-2.8
-1.9
0.3
-2.6
-0.6
1.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-36-29.32.5-13.2
-37.2
-15.7
-12.3
-11.5
-7
-0.6
-5.3
-6.2
-1.5
0.9
-1.6
-11.1
-4.1
-0.2
-1.2
0.2
1.4
-0.7
-0.1
-0.7
-0.6
-0.9
-0.2
-0.2
0.8
-0.7
-0.7
0.3
-0.1

cash-flows.row.account-payables

8.480.62.62.6
8
4.4
7.6
-2.6
3.4
-0.1
1.2
0.3
2.5
-1.4
-2.4
3.2
1.6
1.3
-0.2
0.3
-0.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

12.77-6.8-10.513.1
12.4
7.6
21.6
9.4
6.8
1.5
3.9
-0.5
1.4
1.8
3
2.6
2
1.4
-0.2
-2
-2.1
0.3
-3.4
2.1
-1.5
1.8
-1.2
0
0.3
-1.1
-0.1
0.6
-0.6

cash-flows.row.other-non-cash-items

-60.6395.8-3410.7
-28.8
5.3
-7.2
-0.4
2.1
2.1
1.2
1
2.5
-3.1
2.2
8.1
0.3
13.9
0.1
0
0.5
0.3
0
0
0
0
0
0
-0.2
0.1
0.1
0.2
3

cash-flows.row.net-cash-provided-by-operating-activities

250.98000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.acquisitions-net

0-82.8-52.20
0
0
0
0
-15.7
0
0
1.7
3.8
4.6
5.6
0
0
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-745.81-805.9-582.3-632.2
-404.3
-331.8
-281.4
-261.7
-100.5
-87.8
-49.4
-24.5
-8
-11.9
-60.2
-66.4
-17.7
-29
-39.5
-39
-14.6
-38
-27
-8.3
-25.5
0
0
0
-1.3
-2.9
-4.3
0
0

cash-flows.row.sales-maturities-of-investments

616.66543.5464.5550.8
331.9
206.9
205.5
219.6
71.5
68.3
42
8.8
7
17.8
37.1
34.5
35.2
42
42.2
10.2
30.4
14.4
29.4
12.7
40.4
0
0
2.7
0
6.2
4.9
0
5.5

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
-1.7
-3.4
0
-5.6
-5.1
0
0
0
0
-0.1
0
0
0
0
-2.5
0
-0.8
0.7
0
0.1
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

-162.91-381-223.3-125.5
-116.5
-180.8
-126.3
-57.7
-49.9
-22.3
-10.3
-17.5
-2.4
8.8
-26.8
-40.9
15.1
7.4
1.9
-29.2
14.8
-25.2
-0.1
3.1
13.3
-18.5
-1.6
1.6
-0.7
3.1
0.4
-0.1
5.2

cash-flows.row.debt-repayment

0000
0
-0.5
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

10.357.25.55.1
3.1
2.4
1.7
1.1
0.8
-0.3
-0.3
0.4
0.3
0.3
42.2
3.9
66.6
2.2
4.1
1.6
0.3
1
0.9
96.3
0.8
20.3
0.5
0.1
0
0.1
0.1
0.1
1.4

cash-flows.row.common-stock-repurchased

-126.620-11.3-84.9
0
0
0
0
0
-0.4
-15.3
0
0
0
0
-1.9
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-19.26-9.4-2.2-37.9
-58.8
-11
2.6
6
8.7
10.3
3.7
14.3
1.1
0.6
4
0
0
0
0
0
-0.1
-0.5
-0.2
0.6
0
0
0
0
0
0
-0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-135.53-2.2-8.1-117.7
-55.8
-9.1
3.9
7.2
9.5
9.6
-11.8
14.7
1.4
1
46.2
2.1
66.6
2.1
4.1
1.6
0.3
0.5
0.6
96.9
0.8
20.3
0.5
0.1
0
0.1
0
0.1
1.4

cash-flows.row.effect-of-forex-changes-on-cash

-12.08-2.1-2.8-0.4
-1.9
1.3
-1.8
-0.4
-1.5
0.6
-0.9
-0.7
0.4
0.6
-1.4
0.1
0
0.1
-0.1
0.1
0
0
0
0
0
0
0
0
0
0.3
0
3.5
-1.2

cash-flows.row.net-change-in-cash

-59.55-99.940.471.3
78
3.9
-9.2
25.8
1.5
11.5
3.5
0.2
1
3
-0.3
-67.6
61.8
0.2
0.8
-37.7
-1.1
-44.8
-11.5
92.6
6.6
1.1
-1.3
2.3
0.2
0.1
-3.9
0.1
1.4

cash-flows.row.cash-at-end-of-period

639.9132.8232.7192.3
121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.9
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.7
0.8
0.8
8.1
6.8

cash-flows.row.cash-at-beginning-of-period

699.45232.7192.3121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.8
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.6
0.5
0.7
4.7
8
5.4

cash-flows.row.operating-cash-flow

250.98285.4274.6314.9
252.2
192.5
115.1
76.8
43.3
23.5
26.4
3.6
1.6
-7.4
-18.3
-28.9
-19.8
-9.3
-5.2
-10.1
-16.2
-20.1
-12
-7.3
-7.4
-0.7
-0.2
0.6
0.9
-3.4
-4.3
-3.4
-4

cash-flows.row.capital-expenditure

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.free-cash-flow

217.22249.6221.2270.9
208.2
136.7
64.7
61.2
38.1
20.7
23.6
1.9
-0.2
-9.2
-22.1
-32.7
-22.2
-12.4
-5.9
-10.6
-17
-21.7
-14.5
-8.7
-9
-16.7
-1.8
0.2
0.8
-3.6
-4.6
-3.5
-4.2

Gelir Tablosu Satırı

Abiomed, Inc.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin ABMD brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

income-statement-row.row.total-revenue

1074.11031.8847.5840.9
769.4
593.7
445.3
329.5
230.3
183.6
158.1
126.4
101.2
85.7
73.2
58.9
50.6
43.7
38.2
25.7
23.3
26.9
24.9
22.5
22.1
22.4
16.5
12.8
9.2
6.7
3.4
2.7
2
3
2.9
4.2
4.7

income-statement-row.row.cost-of-revenue

200.59188.2161.9151.3
129.6
98.6
70.6
50.4
39.9
37.3
31.6
24.5
22
22.5
20.4
15.1
12
11.7
9.4
7.6
7.5
7.9
7.4
5.9
6.8
6.5
5.4
3.9
2.9
1.9
3
2
1.3
1
1.1
0.2
3.7

income-statement-row.row.gross-profit

873.51843.6685.6689.6
639.9
495.2
374.7
279.1
190.4
146.3
126.5
101.9
79.2
63.2
52.8
43.9
38.6
32
28.9
18.1
15.8
18.9
17.5
16.6
15.3
15.9
11.1
8.9
6.3
4.8
0.4
0.7
0.7
2
1.8
4
1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

167.22---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.operating-expenses

619.4586.9456.1440.4
415.1
338
284.5
214
161.7
138
110
100.3
90.4
88.3
82.3
80.4
66.3
62.3
32.1
28.4
35.3
43.6
35.1
28.2
23.2
16.9
10.9
9
7.2
7.1
4.9
7
9.1
5.4
5
5.3
1.1

income-statement-row.row.cost-and-expenses

819.99775618591.7
544.6
436.6
355.2
264.4
201.6
175.3
141.6
124.9
112.3
110.8
102.7
95.4
78.4
74
41.5
36
42.8
51.5
42.5
34.1
30
23.4
16.3
12.9
10.1
9
7.9
9
10.4
6.4
6.1
5.5
4.8

income-statement-row.row.interest-income

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.total-operating-expenses

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

30.4828.117.48.3
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.ebitda-caps

284.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

253.61372.7229.6249.2
224.8
157.1
90.1
65.1
28.7
8.4
16.5
1.5
-11.2
-25.1
-29.5
-36.5
-28.5
-30.3
-3.3
-10.3
-19.5
-24.6
-17.6
-11.6
-7.9
-1
0.2
0
-0.9
-2.3
-4.5
-6.3
-8.4
-3.4
-3.2
-1.3
-0.1

income-statement-row.row.income-before-tax

341.16190.6288.2256.8
263.4
160.4
91.3
65.8
28.8
8.5
16.9
2.5
-10.9
-18.4
-30.8
-40.4
-27.4
-29.1
-2.3
-9.4
-18.2
0
0
0
0
0
0
0
-0.5
-1.9
-3.9
-5.1
-6.7
-1.9
-2.3
-0.6
0.1

income-statement-row.row.income-tax-expense

74.454.162.753.8
4.3
48.3
39.2
27.7
-84.9
1.2
1.8
1
0.9
0.7
0.8
0.5
0.5
0.4
0.1
0.2
0.2
-2.9
-6.2
-1.1
-1.2
1.5
-0.5
-0.5
-0.5
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6
-1.9
-2.2
-0.6
0.1
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
EAR
Eargo, Inc..
2.58 USD
NASDAQ
ELEAF
EL.En. S.p.A..
9.8 USD
PNK
FORZ
Forza Innovations Inc..
0.0001 USD
PNK
SILK
Silk Road Medical, Inc.
18.97 USD
NASDAQ
UNIVPHOTO.NS
Universus Photo Imagings Limited.
391 INR
NSE
SGMD.V
Salona Global Medical Device Corporation.
0.22 CAD
TSX
HTL.V
Hamilton Thorne Ltd..
1.45 CAD
TSX

Sıkça Sorulan Sorular

Nedir Abiomed, Inc. (ABMD) toplam varlıklar?

Abiomed, Inc. (ABMD) toplam varlıklar 1673393000.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir 543070000.000'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.818'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 5.493'dur.

İşletme net kar marjı nedir?

Net kâr marjı 0.132'dir.

Firma toplam geliri nedir?

Toplam gelir 0.361'dur.

Nedir Abiomed, Inc. (ABMD) net kar (net gelir)?

Net kar (net gelir) 136505000.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 0.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 586889000.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 182335000.000'tir.